Key result
The Healthy China Action 2019-2030 campaign provides strategic guidance, preventive measures, and policy initiatives for managing chronic obstructive pulmonary disease and bronchial asthma.
Population
Chinese population with or at risk for chronic respiratory diseases
Design
Review
Authors
Loading...
May inform Chinese respiratory policy implementation; leaves open outcome evaluation before broader adoption.
This paper outlines the strategic implementation of the Healthy China Action 2019-2030 for the prevention and control of chronic respiratory diseases in China.
Qiu et al. (2019) studied this question. The Healthy China Action 2019-2030 campaign provides strategic guidance, preventive measures, and policy initiatives for managing chronic obstructive pulmonary disease and bronchial asthma.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: